Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 587

1.

Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.

Glintborg D, Petersen MH, Ravn P, Hermann AP, Andersen M.

Acta Obstet Gynecol Scand. 2016 Nov;95(11):1235-1243. doi: 10.1111/aogs.12964.

PMID:
27529295
2.

Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.

Ezeh U, Pall M, Mathur R, Azziz R.

Hum Reprod. 2014 Jul;29(7):1508-17. Epub 2014 May 9.

3.

Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance.

Mario FM, do Amarante F, Toscani MK, Spritzer PM.

Exp Clin Endocrinol Diabetes. 2012 Oct;120(9):511-6. doi: 10.1055/s-0032-1309006. Epub 2012 May 10.

PMID:
22576259
5.

Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.

Durmus U, Duran C, Ecirli S.

J Endocrinol Invest. 2017 May;40(5):487-497. doi: 10.1007/s40618-016-0582-x. Epub 2016 Nov 12.

PMID:
27838846
6.

Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.

Morrison SA, Goss AM, Azziz R, Raju DA, Gower BA.

Hum Reprod. 2017 Jan;32(1):185-192. Epub 2016 Nov 8.

7.

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C.

Clin Endocrinol (Oxf). 2004 Dec;61(6):738-46.

PMID:
15579189
8.

Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.

Wehr E, Möller R, Horejsi R, Giuliani A, Kopera D, Schweighofer N, Groselj-Strele A, Pieber TR, Obermayer-Pietsch B.

Wien Klin Wochenschr. 2009;121(7-8):262-9. doi: 10.1007/s00508-009-1162-2.

PMID:
19562283
9.

Waist-to-height ratio: an accurate anthropometric index of abdominal adiposity and a predictor of high HOMA-IR values in nondialyzed chronic kidney disease patients.

Silva MI, Lemos CC, Torres MR, Bregman R.

Nutrition. 2014 Mar;30(3):279-85. doi: 10.1016/j.nut.2013.08.004. Epub 2013 Dec 12.

PMID:
24332526
10.

Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.

Macut D, Tziomalos K, Božić-Antić I, Bjekić-Macut J, Katsikis I, Papadakis E, Andrić Z, Panidis D.

Hum Reprod. 2016 Jun;31(6):1347-53. doi: 10.1093/humrep/dew076. Epub 2016 Apr 12.

PMID:
27076501
11.

Correlates of increased lean muscle mass in women with polycystic ovary syndrome.

Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA.

Eur J Endocrinol. 2009 Oct;161(4):583-9. doi: 10.1530/EJE-09-0398. Epub 2009 Jul 15.

PMID:
19605540
12.

Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.

Graff SK, Mário FM, Alves BC, Spritzer PM.

Fertil Steril. 2013 Oct;100(4):1081-8. doi: 10.1016/j.fertnstert.2013.06.005. Epub 2013 Jul 2.

PMID:
23830153
13.

Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome.

Barber TM, Golding SJ, Alvey C, Wass JA, Karpe F, Franks S, McCarthy MI.

J Clin Endocrinol Metab. 2008 Mar;93(3):999-1004. Epub 2007 Dec 18.

PMID:
18089693
14.

Body fat composition and distribution in women with polycystic ovary syndrome.

Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.

Gynecol Endocrinol. 2008 Aug;24(8):428-32. doi: 10.1080/09513590802234253.

PMID:
18850379
15.

The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.

Yang HY, Ma Y, Lu XH, Liang XH, Suo YJ, Huang ZX, Lu DC, Qin YF, Luo ZJ.

Ann Endocrinol (Paris). 2015 Oct;76(5):620-7. doi: 10.1016/j.ando.2015.08.002. Epub 2015 Oct 26.

PMID:
26514948
16.
17.

Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.

Pehlivanov B, Mitkov M.

Eur J Contracept Reprod Health Care. 2009 Apr;14(2):153-9. doi: 10.1080/13625180802549962.

PMID:
19340711
18.

Lean mass and insulin resistance in women with polycystic ovary syndrome.

Comerford KB, Almario RU, Kim K, Karakas SE.

Metabolism. 2012 Sep;61(9):1256-60. doi: 10.1016/j.metabol.2012.02.004. Epub 2012 Mar 17.

PMID:
22424820
19.

Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.

Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ.

Hum Reprod. 2013 Mar;28(3):777-84. doi: 10.1093/humrep/des463. Epub 2013 Jan 12.

PMID:
23315061
20.

Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.

Naderpoor N, Shorakae S, Abell SK, Mousa A, Joham AE, Moran LJ, Stepto NK, Spritzer PM, Teede HJ, de Courten B.

J Steroid Biochem Mol Biol. 2018 Mar;177:209-215. doi: 10.1016/j.jsbmb.2017.07.012. Epub 2017 Jul 19.

PMID:
28734987

Supplemental Content

Support Center